indibulin has been researched along with Ovarian Neoplasms in 1 studies
indibulin: Tubulin Modulator/Antineoplastic Agent; structure in first source
Ovarian Neoplasms: Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Marchand, P | 1 |
| Antoine, M | 1 |
| Le Baut, G | 1 |
| Czech, M | 1 |
| Baasner, S | 1 |
| Günther, E | 1 |
1 other study available for indibulin and Ovarian Neoplasms
| Article | Year |
|---|---|
Synthesis and structure-activity relationships of N-aryl(indol-3-yl)glyoxamides as antitumor agents.
Topics: Animals; Antineoplastic Agents; Carcinoma; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Drug Sc | 2009 |